Document is current
Any future updates will be listed below
-
Authors
Conley, Alexander C.
Key, Alexandra P.
Blackford, Jennifer U.
Russell, Jason K.
Albert, Kimberly M.
Gong, Xuewen
Bubser, Michael
Rook, Jerri M.
Conn, P. Jeffrey
Lindsley, Craig W.
Jones, Carrie K.
Newhouse, Paul A.
-
Funding
Funding for this research was provided by:
Alzheimer's Association (PCTR-16-383171)
Alzheimer's Drug Discovery Foundation (21040501.03)
- License Information
-
More Information
Article History
Received: 20 March 2025
Accepted: 24 June 2025
First Online: 1 July 2025
Declarations
:
: This study was approved by the Duke University Institutional Review Board and was performed in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. All participants signed written informed consent documents before participating in the study.
: Vanderbilt University and the Warren Center for Neuroscience Drug Discovery are partnered with Acadia Pharmaceuticals to develop next generation M1 PAMs and hold patents to the same. The other authors have no competing interests to declare.
